Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2002 / Cilt: 36 - Sayı: 3

Anti-gliadin antibodies in psoriasis

Psoriasiste anti-gliadin antikorlarının yeri

Pages
182–187
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: It was found that 16.5% of patients with psoriasis had serum levels of IgA antibodies to gliadin.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Psoriasis is a hyperproliferative and papulosquamous skin disorder that affects 1-2% of the population.
📊
Key Findings & Data:Materials and methods: IgG and IgA type antibodies to gliadin were quantified in 127 patients with psoriasis, the age and sex matched control group of 31 individuals and 6 patients with celiac sprue.
💡
Conclusion & Impact:Results: It was found that 16.5% of patients with psoriasis had serum levels of IgA antibodies to gliadin.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: Psoriasis is a hyperproliferative and papulosquamous skin disorder that affects 1-2% of the population. Despite extensive studies done, aetiology is still to be elucidated. Recently, gluten hypersensitivity and a possible enteropathy are being investigated in psoriasis. As a population, with a diet mainly based on cereals like wheat, we have studied the presence of gluten hypersensitivity in psoriasis and its possible influence on the general manifestations of the disease. Materials and methods: IgG and IgA type antibodies to gliadin were quantified in 127 patients with psoriasis, the age and sex matched control group of 31 individuals and 6 patients with celiac sprue. A possible impact of the presence of antigliadin antibodies on the disease characteristics, namely arthropathy, clinical presentation, age of onset, gastrointestinal symptoms and the presence of a psoriatic family member, was investigated. Results: It was found that 16.5% of patients with psoriasis had serum levels of IgA antibodies to gliadin. Despite being relatively a high percentage when compared to those of the control group (%9.6), it was not a statistically significant increase. The presence of antibodies to gliadin had no influence on the disease characteristics. Conclusion: Despite being insignificant, an increase in the presence of antibodies to gliadin was noted in patients with psoriasis. There seems to be a subgroup of psoriasis patients with positive antibodies to gliadin but subgroup, which might benefit from a gluten-free diet.

Özet

Psoriasis toplumun %1-2'sini etkileyen, hiperproliferatif ve papüloskuamöz bir hastalıktır. Etyolojisi yapılan çok sayıda araştırmaya rağmen tam olarak aydınlatılamamıştır. Son yıllarda psoriatik hastalarda gluten hipersensitivitesi ve buna bağlı olabilecek bir enteropatinin varlığından sözedilmektedir. Buğday gibi tahıl ürünlerini oldukça fazla tüketen toplum olarak, psoriasiste gluten hipersensitivitesinin varlığını ve hastalığın genel özellikleri ile ilişkisini araştırdık. Bu amaçla 127 psoriatik hasta, 31 kişilik kontrol grubu ve 6 kişilik Çölyak hasta grubu, serumda antigliadin IgA ve IgG tip antikorlar ölçülerek karşılaştırıldı. Ayrıca, psoriatik hastalarda, antikorların varlığı ile gastrointestinal şikayetler, artropati, tırnak tutulumu, klinik prezantasyon, hastalığın başlangıç yaşı ve ailede psoriatik bireyin mevcudiyeti arasındaki olası ilişki de araştırılmıştır. Psoriatik hastalarda %16.5 oranında antigliadin IgA antikor pozitifliği saptanmış ancak kontrol grubuna (%9.6) kıyasla anlamlı bir bulgu olmadığı görülmüştür. Antigliadin antikorlarının varlığı hiçbir klinik parametre ile ilişkili bulunmamıştır. Psoriasiste antigliadin antikorlarında, çok anlamlı olmasa da, bir artış olduğu görülmektedir. Gastrointestinal sisteme yönelik şikayetlerden bağımsız ve antigliadin antikorları pozitif olan bir psoriasis alt grubunun mevcudiyeti dikkati çekmektedir. Yapılan diğer araştırmaların ışığında, bu alt grubu saptamak ve yapılabildiği ölçüde glutensiz diyet uygulamak, bu hastalar için yeni bir ümit kaynağı olabilir.

🔖

Cite This Article

KALAYCIYAN, A., ÇELİK, A., TÜMAY, G. T., KOTOĞYAN, A., KUTLU, T. (2022). Anti-gliadin antibodies in psoriasis. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 36 - Sayı: 3, 182–187. https://ajindex.com/articles/622406

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (20)

  1. Shuster S, Watson AJ, Marks J: Small intestine in psoriasis. Br MedJ 1967: 458-460
  2. Michaelsson G, Gerden B: How common is gluten intolerance among patients with psoriasis? Acta Derm Venerol (Stockh) 1991; 71:90
  3. Michaelsson G, Kraaz W, Gerden B, Hagforsen E, Hjelmqvist G, Lööf L, Sjöberg O, Scheynius A: Increased lymphocyte infiltration in duodenal mucosa from patients with psoriasis and serum IgA antibodies to gliadin. Br J Dermatol 1995; 133: 896-904
  4. Henseler T, Christophers E: Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985; 13: 450-456
  5. Troncone R: Gluten sensitive enteropathy. Pediatr Clin North Am 1996; 43: 355-373
  6. Guilhou JJ, Clot J, Meynadier J, Lapinski H: Immunological aspects of psoriasis. Br J Dermatol 1976; 94: 501 -507
  7. Fraser NG, Dick HM, Grichton WB: Immunoglobulins in dermatitis herpetiformis and various other skin diseases. Br J Dermatol 1969; 81:89-94
  8. Sagransky DM, Greenwald RA: Psoriasis associated with selec¬ tive IgA deficiency. Arch Dermatol 1980; 116: 750
  9. Michaelsson G, Gerden B, Ottosson M, Parra A, Sjöberg O, Hjelmquist G, Lööf L: Patients with psoriasis often have increased serum levels of IgA antibodies to gliadin. Br J Dermatol 1993; 129:667-673
  10. Boyd AS, Minter A: Erythrodermic psoriasis. Precipitating factors, course, and prognosis in 50 patients. J Am Acad Dermatol 1989; 21:985-991
  11. Kim TG, Lee HJ, Youn Jl, Kim TY, Han H: The association of psoriasis with human leukocyte antigens in Korean population and the influence of age of onset and sex. J Invest Dermatol 2000; 114:309-313
  12. Tüzün B, Tüzün Y: Psoriasis dipnotları. 2'nci baskı. İstanbul, Nobel Tıp Kitabevleri, 1998; 111-126
  13. Editorial. Diagnosis of coeliac disease. Lancet 1991; 337: 590
  14. Trier JS: Celiac sprue. N Engl J Med 1991; 325: 1709-1719
  15. Kalaycıyan AK, İşçimen A, Kotoğyan A: Bir püstüler psoriasis ol¬ gusunda antigliadin antikor pozitifliği. Türkderm 1999; 33: 48-49
  16. Scott H, Brandtzaeg P: Gluten IgA antibodies and coeliac dis¬ ease. Lancet 1989; 1: 382-383
  17. Konnick CR, Giliams JP, Polanco I, Pena AS: IgA antigliadin antibodies in celiac and inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1984; 3: 676-682
  18. Unsworth DJ, Walker-Smith JA, Holborrow EJ, Fry L: Gliadin and retic- ulin antibodies in childhood coeliac disease. Lancet 1983; 1: 874-875
  19. Marks J: Psoriatic enteropathy. Arch Dermatol 1971; 103: 676-678
  20. Michaels